James E. Flynn, 10% Owner at ARS Pharmaceuticals, Inc. (SPRY), sold 1,480,298 shares at $18.46 ($27.3M) on 2025-06-27, disclosed to the SEC on 2025-07-01.
Open-market sale of $27.3M SPRY by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.46 | 370,074 | $6.8M | 25.0% |
| 2 | $18.46 | 370,074 | $6.8M | 25.0% |
| 3 | $18.46 | 370,075 | $6.8M | 25.0% |
| 4 | $18.46 | 370,075 | $6.8M | 25.0% |
| Total | $18.46 avg | 1,480,298 | $27.3M | 100% |
| Filing → |
| ONCR | SELL | 2022-12-30 | $65K | — | Filing → |
| ONCR | SELL | 2022-12-21 | $23K | — | Filing → |
| AFIB | BUY | 2021-07-21 | $15.0M | — | Filing → |